Post from October 6, 2022
WASHINGTON, D.C. – Today Congresswoman Anna G. Eshoo (D-CA) announced five National Institute of Health (NIH) grants totaling $5.1 million for high-risk, high-reward behavioral and biomedical research programs at Stanford University.
“These grants are rewarded to our nation’s top scientists who are conducting visionary behavioral and biomedical research. Brava to the five brilliant researchers at Stanford who received these awards for their highly innovative projects that have the potential to change the world,” said Eshoo.
The grants are part of NIH’s High-Risk, High-Reward Research Program, which has awarded 103 new research grants to support innovative scientists who propose groundbreaking and broadly impactful behavioral and biomedical research projects. The 103 awards total approximately $285 million over five years beginning in 2022.
The specific grant recipients at Stanford and research projects are listed below:
- Andrew J. Beel received a $393,661 “Early Independence” award for a projected entitled “Structure and Pharmacologic Modulation of the Mitotic Chromosomes Central Axis.”
- Serena Sanulli received a $1,416,600 “New Innovator” award for a project entitled “Harnessing the chromatin conformational code for epigenetic regulation.”
- Mark Skylar-Scott received a $1,416,600 “New Innovator” award for a project entitled “Trillion cell culture to fuel organ biofabrication.”
- Sherri Rose received a $1,087,100 “Pioneer” award for a project entitled “A Framework for the Social Impact of Algorithms in Health Care.”
- Michael Andrew Fischbach received a $794,261 “Transformative Research” award for a project entitled “Building the foundations of commensal vaccines.”
Original source can be found here.
